Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration

Journal of Neural Transmission

Volumn 104, Issue 8-9, 1997, Pages 867-874

  Barbier, P ^a   Colelli, A ^a   Maggio, R ^a   Bravi, D ^b   Corsini, G U ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNS Department   (Italy)

Author keywords

Dopamine receptor; Pergolide; Receptor binding; Receptor sequestration

Indexed keywords

3 METHYLSPIPERONE; DOPAMINE 2 RECEPTOR; PERGOLIDE;

ANIMAL CELL; ARTICLE; DISSOCIATION; ENDOCYTOSIS; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030725557     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01285554     Document Type: Article

References (15)

1. Cullen BR (1987) Use of eucaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152: 684-704
2. Fisher SK (1988) Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Mol Pharmacol 33: 414-422
3. Goldstein M, Lieberman A, Lew J, Asano T, Rosenfeld MR, Makman MH (1980) Interaction of pergolide with central dopaminergic receptors. Proc Natl Acad Sci USA 77: 3725-3728
4. Harden TK, Petch LA, Traynelis SF, Waldo GL (1985) Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors. J Biol Chem 260: 13060-13066
5. Itokawa M, Toru M, Ito K, Tsuga H, Kameyama K, Haga T, Arinami T, Hamaguchi H (1996) Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 49: 560-566
6. Lemberger L, Crabtree RE (1979) Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist. Science 205: 1151-1153
7. Lew JY, Nakamura S, Battista AF, Goldstein M (1970) Dopamine agonist potencies of ergolines. Psychopharmacology 3: 179-183
8. Masters SB, Quinn MT, Brown JH (1985) Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis. Mol Pharmacol 27: 325-332
9. Monsma FJ, McVittie LD, Gerfen CR, Mahan LC, Sibley DR (1989) Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342: 926-929
10. Ng GYK, Mouillac B, George SR, Caron M, Dennis M, Bouvier M, O'Dowd BF (1994) Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol (Mol Pharmacol Sect) 267: 7-19
11. O'Dowd BF (1993) Structures of dopamine receptors. J Neurochem 60: 804-816
12. Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J, et al (1994) A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Mov Disord 9: 40-47
13. Seeman P, Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15: 264-270
14. Von Zastrow M, Kobilka BK (1994) Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J Biol Chem 269: 18448-18452
15. Yu SS, Lefkowitz RJ, Hausdorff WP (1993) β-adrenergic receptor sequestration: a potential mechanism of receptor resensitization. J Biol Chem 268: 337-341